M. James Barrett, 10% Owner at Ra Pharmaceuticals, Inc. (RARX), sold 435 shares at $13.00 ($6K) on 2016-10-31, disclosed to the SEC on 2016-10-31.
Open-market sale of $6k RARX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GLYC | SELL | 2018-05-11 | $340K | — | Filing → |
| SURF | BUY | 2018-04-23 | $2.0M | — | Filing → |
| ADAP | BUY | 2018-03-28 | $13.7M | — | Filing → |